Sriram Ramgopal, Vishal V Naik, Sho Komukai, Sylvia Owusu-Ansah, Remle P Crowe, Masashi Okubo, Christian Martin-Gill
{"title":"入院前全身使用皮质类固醇与哮喘加重患者在急诊科和住院期间的治疗效果之间的关系。","authors":"Sriram Ramgopal, Vishal V Naik, Sho Komukai, Sylvia Owusu-Ansah, Remle P Crowe, Masashi Okubo, Christian Martin-Gill","doi":"10.1111/acem.14890","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Timely administration of systemic corticosteroids is a cornerstone of asthma exacerbation treatment, yet little is known regarding potential benefits of prehospital administration by emergency medical services (EMS) clinicians. We examined factors associated with prehospital corticosteroid administration with hospitalization and hospital length of stay (LOS).</p><p><strong>Methods: </strong>We performed a retrospective study of EMS encounters for patients 2-50 years of age with suspected asthma exacerbation from a national data set. We evaluated factors associated with systemic corticosteroid administration using generalized estimating equations. We performed propensity matching based on service level, age, encounter duration, vital signs, and treatments to evaluate the association of prehospital corticosteroid administration with hospitalization and LOS using weighted logistic regression. We evaluated the association of prehospital corticosteroid administration with admission using Bayesian models.</p><p><strong>Results: </strong>Of 15,834 encounters, 4731 (29.9%) received prehospital systemic corticosteroids. Administration of corticosteroids was associated with older age; sex; urbanicity; advanced life support provider; vital sign instability; increasing doses of albuterol; and provision of ipratropium bromide, magnesium, epinephrine, and supplementary oxygen. Within the matched sample, prehospital corticosteroids were not associated with hospitalization (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.73-1.01) or LOS (multiplier 0.76, 95% CI 0.56-1.05). Administration of corticosteroids was associated with lower odds of admission and shorter LOS in longer EMS encounters (>34 min), lower admission odds in patients with documented wheezing, and shorter LOS among patients treated with albuterol. In a Bayesian model with noninformative priors, the OR for admission among encounters given corticosteroids was 0.86 (95% credible interval 0.77-0.96).</p><p><strong>Conclusions: </strong>Prehospital systemic corticosteroid administration was not associated with hospitalization or LOS in the overall cohort of asthma patients treated by EMS, though they had a lower probability of admission within Bayesian models. Improved outcomes were noted among subgroups of longer EMS encounters, documented wheezing, and receipt of albuterol.</p>","PeriodicalId":7105,"journal":{"name":"Academic Emergency Medicine","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association of prehospital systemic corticosteroids with emergency department and in-hospital outcomes for patients with asthma exacerbations.\",\"authors\":\"Sriram Ramgopal, Vishal V Naik, Sho Komukai, Sylvia Owusu-Ansah, Remle P Crowe, Masashi Okubo, Christian Martin-Gill\",\"doi\":\"10.1111/acem.14890\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Timely administration of systemic corticosteroids is a cornerstone of asthma exacerbation treatment, yet little is known regarding potential benefits of prehospital administration by emergency medical services (EMS) clinicians. We examined factors associated with prehospital corticosteroid administration with hospitalization and hospital length of stay (LOS).</p><p><strong>Methods: </strong>We performed a retrospective study of EMS encounters for patients 2-50 years of age with suspected asthma exacerbation from a national data set. We evaluated factors associated with systemic corticosteroid administration using generalized estimating equations. We performed propensity matching based on service level, age, encounter duration, vital signs, and treatments to evaluate the association of prehospital corticosteroid administration with hospitalization and LOS using weighted logistic regression. We evaluated the association of prehospital corticosteroid administration with admission using Bayesian models.</p><p><strong>Results: </strong>Of 15,834 encounters, 4731 (29.9%) received prehospital systemic corticosteroids. Administration of corticosteroids was associated with older age; sex; urbanicity; advanced life support provider; vital sign instability; increasing doses of albuterol; and provision of ipratropium bromide, magnesium, epinephrine, and supplementary oxygen. Within the matched sample, prehospital corticosteroids were not associated with hospitalization (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.73-1.01) or LOS (multiplier 0.76, 95% CI 0.56-1.05). Administration of corticosteroids was associated with lower odds of admission and shorter LOS in longer EMS encounters (>34 min), lower admission odds in patients with documented wheezing, and shorter LOS among patients treated with albuterol. In a Bayesian model with noninformative priors, the OR for admission among encounters given corticosteroids was 0.86 (95% credible interval 0.77-0.96).</p><p><strong>Conclusions: </strong>Prehospital systemic corticosteroid administration was not associated with hospitalization or LOS in the overall cohort of asthma patients treated by EMS, though they had a lower probability of admission within Bayesian models. Improved outcomes were noted among subgroups of longer EMS encounters, documented wheezing, and receipt of albuterol.</p>\",\"PeriodicalId\":7105,\"journal\":{\"name\":\"Academic Emergency Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Academic Emergency Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/acem.14890\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"EMERGENCY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic Emergency Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/acem.14890","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
背景:及时使用全身性皮质类固醇是治疗哮喘加重的基石,但人们对急救医疗服务(EMS)临床医生院前使用皮质类固醇的潜在益处知之甚少。我们研究了院前使用皮质类固醇与住院和住院时间(LOS)的相关因素:我们对全国数据集中 2-50 岁疑似哮喘加重患者的急救服务接诊情况进行了回顾性研究。我们使用广义估计方程评估了与全身使用皮质类固醇相关的因素。我们根据服务水平、年龄、就诊时间、生命体征和治疗方法进行倾向匹配,使用加权逻辑回归评估院前使用皮质类固醇与住院和 LOS 的关系。我们使用贝叶斯模型评估了院前使用皮质类固醇与入院的关系:在 15834 次就诊中,4731 人(29.9%)接受了院前全身皮质类固醇治疗。皮质类固醇的使用与年龄、性别、城市化程度、高级生命支持提供者、生命体征不稳定、阿布特罗剂量增加、异丙托溴铵、镁、肾上腺素和辅助供氧有关。在匹配样本中,院前皮质类固醇与住院(几率比 [OR] 0.86,95% 置信区间 [CI] 0.73-1.01)或 LOS(乘数 0.76,95% 置信区间 0.56-1.05)无关。在急救时间较长(>34 分钟)的患者中,使用皮质类固醇与较低的入院几率和较短的 LOS 相关,在有喘息记录的患者中,使用皮质类固醇与较低的入院几率相关,而在使用阿布特罗治疗的患者中,使用皮质类固醇与较短的 LOS 相关。在非信息先验的贝叶斯模型中,使用皮质类固醇治疗的患者入院几率为 0.86(95% 可信区间为 0.77-0.96):结论:在接受急救医疗服务的哮喘患者总体队列中,院前全身使用皮质类固醇与住院或住院时间无关,尽管在贝叶斯模型中他们入院的概率较低。在急救时间较长、有喘息记录和接受过盐酸克仑特罗治疗的亚组中,治疗效果有所改善。
The association of prehospital systemic corticosteroids with emergency department and in-hospital outcomes for patients with asthma exacerbations.
Background: Timely administration of systemic corticosteroids is a cornerstone of asthma exacerbation treatment, yet little is known regarding potential benefits of prehospital administration by emergency medical services (EMS) clinicians. We examined factors associated with prehospital corticosteroid administration with hospitalization and hospital length of stay (LOS).
Methods: We performed a retrospective study of EMS encounters for patients 2-50 years of age with suspected asthma exacerbation from a national data set. We evaluated factors associated with systemic corticosteroid administration using generalized estimating equations. We performed propensity matching based on service level, age, encounter duration, vital signs, and treatments to evaluate the association of prehospital corticosteroid administration with hospitalization and LOS using weighted logistic regression. We evaluated the association of prehospital corticosteroid administration with admission using Bayesian models.
Results: Of 15,834 encounters, 4731 (29.9%) received prehospital systemic corticosteroids. Administration of corticosteroids was associated with older age; sex; urbanicity; advanced life support provider; vital sign instability; increasing doses of albuterol; and provision of ipratropium bromide, magnesium, epinephrine, and supplementary oxygen. Within the matched sample, prehospital corticosteroids were not associated with hospitalization (odds ratio [OR] 0.86, 95% confidence interval [CI] 0.73-1.01) or LOS (multiplier 0.76, 95% CI 0.56-1.05). Administration of corticosteroids was associated with lower odds of admission and shorter LOS in longer EMS encounters (>34 min), lower admission odds in patients with documented wheezing, and shorter LOS among patients treated with albuterol. In a Bayesian model with noninformative priors, the OR for admission among encounters given corticosteroids was 0.86 (95% credible interval 0.77-0.96).
Conclusions: Prehospital systemic corticosteroid administration was not associated with hospitalization or LOS in the overall cohort of asthma patients treated by EMS, though they had a lower probability of admission within Bayesian models. Improved outcomes were noted among subgroups of longer EMS encounters, documented wheezing, and receipt of albuterol.
期刊介绍:
Academic Emergency Medicine (AEM) is the official monthly publication of the Society for Academic Emergency Medicine (SAEM) and publishes information relevant to the practice, educational advancements, and investigation of emergency medicine. It is the second-largest peer-reviewed scientific journal in the specialty of emergency medicine.
The goal of AEM is to advance the science, education, and clinical practice of emergency medicine, to serve as a voice for the academic emergency medicine community, and to promote SAEM''s goals and objectives. Members and non-members worldwide depend on this journal for translational medicine relevant to emergency medicine, as well as for clinical news, case studies and more.
Each issue contains information relevant to the research, educational advancements, and practice in emergency medicine. Subject matter is diverse, including preclinical studies, clinical topics, health policy, and educational methods. The research of SAEM members contributes significantly to the scientific content and development of the journal.